ELIZABETH MCGOWAN: Open Payments
NPI 1740382589 · PALM SPRINGS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$551 in 23 payments from 11 companies in 2025. Trend: 2023 $721 · 2024 $667 · 2025 $551
Food & beverage: $551
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 7 | $220 |
| ABBVIE INC. | 3 | $65 |
| Gilead Sciences, Inc. | 2 | $51 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $48 |
| Intercept Pharmaceuticals, Inc. | 2 | $32 |
| Ardelyx, Inc. | 1 | $32 |
| Phathom Pharmaceuticals, Inc. | 2 | $25 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| Phadia US Inc. | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
Products named: REZDIFFRA, MAVYRET, ENTYVIO, OCALIVA, IBSRELA, VOQUEZNA, DUPIXENT, ImmunoCAP.
Industry payments across CA — which companies pay providers there.
